Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 April 2011: Case Study  

Unusual recurrence of trigeminal neuralgia after microvascular decompression by muscle interposal

Giovanni Grasso AE , Franceso Meli B , Rosario Maugeri EF , Francesco Certo F , Gabriele Costantino F , Filippo Giambartino BC , Domenico G. Iacopino D

DOI: 10.12659/MSM.881703

Med Sci Monit 2011; 17(4): CS43-46

0 Comments

Background

The concept of vascular compression of cranial nerves in the posterior fossa has developed from several lines of evidence. Over the past few years, microvascular decompression (MVD) has been shown to be effective [1–3].

To date, MVD is the first surgical treatment option for trigeminal neuralgia (TN) and other cranial nerve hyperactive dysfunctions. Although this technique has a high rate of success with respect to pain relief and long-term benefit [4], pain can recur and re-exploration may be indicated in a subgroup of patients [5]. There have been several reports of recurrent TN, some of which are related to the prosthesis used for separating the offending vessel and the nerve [6–8].

In this paper we report on a patient with pain recurrence after MVD for TN caused by a muscle fragment piercing the trigeminal nerve and encasing the offending artery.

Case Report

A 48-year-old woman presented with a long history of right TN within the ophthalmic and mandibular divisions, which failed to respond to medical management. The patient underwent brain magnetic resonance angiography (MRA), revealing neurovascular compression at the dorsal root entry zone of the right fifth cranial nerve and also underwent MVD with right SCA displacement and muscle interposition. The neuralgia resolved immediately after surgery, but recurred 3 years later with the same distribution. The pain was refractory to medical management. MRA was performed again but did not show any trigeminal vascular compression. The patient underwent percutaneous rhizotomies, performed at another centre, without effect.

Considering that most recurrences occur within 2 years following surgery, and that new arterial loop compression, regrowth of veins, or incomplete decompression at the first surgical treatment are the main causes, a decision was made to conduct surgical re-exploration.

During the operation, the fifth cranial nerve was seen without impingement from any blood vessels. However, inferiorly to the nerve and directly against it, a solid tissue was observed that was identified as the muscle fragment from the previous MVD procedure. This tissue was distorting and stretching the nerve and encasing the right SCA (Figure 1). The fifth cranial nerve was carefully separated from the muscle. Thereafter, the right SCA was dissected out from the muscle and suspended by a periosteum tape sutured to the nearby dura.

The patient had no intraoperative or postoperative complications. At 2-year follow-up the patient was pain-free without medication.

Discussion

The concept of vascular compression of cranial nerves in the posterior fossa has developed from several lines of evidence. Dandy first proposed the fifth cranial nerve compression, at its point of entry into the pons, by the superior cerebellar artery, as a possible cause of trigeminal neuralgia [9]. Subsequent reports confirmed that patients with trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia had blood vessels in close contact with the respective cranial nerve, and that separating the blood vessel from the nerve by interposing a soft implant between them (microvascular decompression) could be curative [1–3].

Pathophysiological mechanisms underlying cranial nerve hyperactive dysfunction after vascular compression have been investigated extensively and partially clarified. Briefly, it has been suggested that these clinical syndromes result from pulsatile compression by arteries at the root entry/exit zone of the cranial nerve, a junctional area between central and peripheral myelin [3]. Over the past several years, this concept has been widely accepted and has stimulated several studies addressed primarily at establishing precise patient selection criteria [10]. With the advent of magnetic resonance imaging, which, using specific three-dimensional sequences [11–13], has offered a good visualization of both cranial nerves and cerebral vessels, neurovascular compression disorders have been diagnosed with increasing frequency, thus providing additional evidence supporting MVD treatment.

To date, MVD is associated with a high incidence of pain relief and long-term success since about 70% of patients remain pain-free and off medication for at least 10 years following the procedure [4]. Recurrence may occur in 18–30% of patients, mainly within 2 years of surgery and thereafter at a rate of 2–5% per year [4,14]. This occurrence has been attributed to several causes, including new arterial loop compression, regrowth of new veins, incomplete decompression and problems related to the interposed material [6–8,15–17]. In addition, arachnoid thickening or granulomatous severe adhesion between the nerve and the surrounding structures following the first MVD surgery has been reported [18,19]. In up to 44% of patients no factor explaining the recurrence can be identified [20,21].

In this paper we described the recurrence of TN in which autologous muscle was used as interposing material during the first operation. At the re-operation the muscle formed a very firm tissue that distorted and stretched the trigeminal nerve. It also encased the right SCA, thus transmitting the vascular pulsations into the nerve.

In our experience, the use of autologous muscle as interposing material between nerve and vessel has been shown to be safe, with a recurrence rate similar to those cases in which Teflon and other synthetic materials have been employed. Conceptually, the use of muscle arises from the idea that an autologous material should be safer and better tolerated than a synthetic prosthesis [22,23]. However, dissolution of the implant and recurrent vascular compression of the trigeminal root entry zone related to the use of resorbable materials, such as muscle, periosteum, collagen foam, or lyophilized dura, has been reported [24]. Synthetic materials, such as Teflon or Ivalon sponges have also been associated with a direct subsequent neurovascular compression by the same vessel because of a slipped prosthesis [7]. Compression of the trigeminal root entry zone, caused by the prosthesis itself or by severe adhesions, has been reported by several authors [25,26], and even indirect vascular compression caused by fairly hard implants like Ivalon has been reported [27,28]. Many other reports have also focused on adverse reactions to synthetic materials. Teflon-induced granuloma has been documented in various reports [25,29,30].

Based on these experiences, some authors have recently advocated alternative techniques such as the “hanging technique”, where the offending vessel is transposed from the nerve by using strips of autologous tissue or fenestrated clips for aneurysm surgery [31,32]. This technique, used in our case and already suggested by our group for the treatment of medulla oblongata compression by vertebral artery [33,34], seems to be a useful method, especially in cases such as we report, in which recurrence of the TN can be related to compression or adhesion caused by the material used in the first MVD.

Conclusions

In this paper we report on a patient with pain recurrence after MVD for TN caused by a muscle fragment that had pierced the trigeminal nerve and encased the offending artery.

Successful long-term outcome following MVD in cranial nerve dysfunction disease depends primarily on maintaining the isolation between the nerve and the offending vessel. For this reason development of new inert materials and use of alternative surgical strategies can limit TN recurrence.

References

1. Gardner W, Miklos M, Response of trigeminal neuralgia to decompression of sensory root; discussion of cause of trigeminal neuralgia: J Am Med Assoc, 1959; 170

2. Hongo K, Kobayashi S, Takemae T, Posterior fossa microvascular decompression for hemifacial spasm and trigeminal neuralgia-some improvements on operative devices and technique: No Shinkei Geka, 1985; 13; 1291-96, pmid: 4088451

3. Jannetta P, Neurovascular compression in cranial nerve and systemic disease: Ann Surg, 1980; 192; 518-25, pmid: 6968543

4. Barker FG, Jannetta PJ, Bissonette DJ, The long-term outcome of microvascular decompression for trigeminal neuralgia: N Engl J Med, 1996; 334; 1077-83, pmid: 8598865

5. Amador N, Pollock BE, Repeat posterior fossa exploration for patients with persistent or recurrent idiopathic trigeminal neuralgia: J Neurosurg, 2008; 108; 916-20, pmid: 18447706

6. Fujimaki T, Hoya K, Sasaki T, Recurrent trigeminal neuralgia caused by an inserted prosthesis: report of two cases: Acta Neurochir (Wien), 1996; 138; 1307-10, pmid: 8980734

7. Liao JJ, Cheng WC, Chang CN, Reoperation for recurrent trigeminal neuralgia after microvascular decompression: Surg Neurol, 1997; 47; 562-68, pmid: 9167781 discussion 568–70

8. Vitali AM, Sayer FT, Honey CR, Recurrent trigeminal neuralgia secondary to Teflon felt: Acta Neurochir (Wien), 2007; 149; 719-22, pmid: 17565427 discussion 722

9. Dandy W, Concerning the cause of trigeminal neuralgia: Am J Surg, 1934; 24; 445-55

10. Jannetta P, Selection criteria for the treatment of cranial rhizopathies by microvascular decompression (honored guest lecture): Clin Neurosug, 1997; 44; 69-77

11. Furuya Y, Ryu H, Uemura K, MRI of intracranial neurovascular compression: J Comput Assist Tomogr, 1992; 16

12. Miller J, Acar F, Hamilton B, Preoperative visualization of neurovascular anatomy in trigeminal neuralgia: J Neurosurg, 2008; 108; 477-82, pmid: 18312094

13. Satoh T, Omi M, Nabeshima M, Severity analysis of neurovascular contact in patients with trigeminal neuralgia: assessment with the inner view of the 3D MR cisternogram and angiogram fusion imaging: AJNR Am J Neuroradiol, 2009; 30; 603-7, pmid: 19039051

14. Olson S, Atkinson L, Weidmann M, Microvascular decompression for trigeminal neuralgia: recurrences and complications: J Clin Neurosci, 2005; 12; 787-89, pmid: 16165362

15. Lee SH, Levy EI, Scarrow AM, Recurrent trigeminal neuralgia attributable to veins after microvascular decompression: Neurosurgery, 2000; 46; 356-61, pmid: 10690724 discussion 361–62

16. Broggi G, Ferroli P, Franzini A, Microvascular decompression intervention in the treatment of trigeminal neuralgia: Recenti Prog Med, 2001; 92; 164-68, pmid: 11294111

17. Kouyialis AT, Stranjalis G, Boviatsis EJ, Recurrence of trigeminal neuralgia due to an acquired arachnoid cyst: J Clin Neurosci, 2008

18. Kondo A, Follow-up results of microvascular decompression in trigeminal neuralgia and hemifacial spasm: Neurosurgery, 1997; 40; 46-51, pmid: 8971823 discussion 51–52

19. Ishikawa M, Nishi S, Aoki T, Operative findings in cases of trigeminal neuralgia without vascular compression: proposal of a different mechanism: J Clin Neurosci, 2002; 9; 200-4, pmid: 11922717

20. Rath SA, Klein HJ, Richter HP, Findings and long-term results of subsequent operations after failed microvascular decompression for trigeminal neuralgia: Neurosurgery, 1996; 39; 933-38, pmid: 8905748 discussion 938–40

21. Meaney JF, Eldridge PR, Dunn LT, Demonstration of neurovascular compression in trigeminal neuralgia with magnetic resonance imaging. Comparison with surgical findings in 52 consecutive operative cases: J Neurosurg, 1995; 83; 799-805, pmid: 7472546

22. Tomasello F, Alafaci C, Angileri FF, Clinical presentation of trigeminal neuralgia and the rationale of microvascular decompression: Neurol Sci, 2008; 29(Suppl 1); S191-95, pmid: 18545932

23. Alafaci C, Salpietro FM, Montemagno G, Spasmodic torticollis due to neurovascular compression of the spinal accessory nerve by the anteroinferior cerebellar artery: case report: Neurosurgery, 2000; 47; 768-71, pmid: 10981767 discussion 771–72

24. Klun B, Microvascular decompression and partial sensory rhizotomy in the treatment of trigeminal neuralgia: personal experience with 220 patients: Neurosurgery, 1992; 30; 49-52, pmid: 1371184

25. Cho DY, Chang CG, Wang YC, Repeat operations in failed microvascular decompression for trigeminal neuralgia: Neurosurgery, 1994; 35; 665-69, pmid: 7808609 discussion 669–70

26. Yamaki T, Hashi K, Niwa J, Results of reoperation for failed microvascular decompression: Acta Neurochir (Wien), 1992; 115; 1-7, pmid: 1595390

27. Goya T, Wakisaka S, Kinoshita K, Microvascular decompression for trigeminal neuralgia with special reference to delayed recurrence: Neurol Med Chir (Tokyo), 1990; 30; 462-67, pmid: 1701856

28. Jannetta PJ, Bissonette DJ, Management of the failed patient with trigeminal neuralgia: Clin Neurosurg, 1985; 32; 334-47, pmid: 3905144

29. Megerian CA, Busaba NY, McKenna MJ, Teflon granuloma presenting as an enlarging, gadolinium enhancing, posterior fossa mass with progressive hearing loss following microvascular decompression: Am J Otol, 1995; 16; 783-86, pmid: 8572142

30. Premsagar IC, Moss T, Coakham HB, Teflon-induced granuloma following treatment of trigeminal neuralgia by microvascular decompression. Report of two cases: J Neurosurg, 1997; 87; 454-57, pmid: 9285615

31. Mitsos AP, Georgakoulias N, Lafazanos SA, The “hanging technique” of vascular transposition in microvascular decompression for trigeminal neuralgia: technical report of four cases: Neurosurg Rev, 2008; 31; 327-30, pmid: 18470545

32. Attabib N, Kaufmann AM, Use of fenestrated aneurysm clips in microvascular decompression surgery. Technical note and case series: J Neurosurg, 2007; 106; 929-31, pmid: 17542544

33. Tomasello F, Alafaci C, Salpietro FM, Bulbar compression by an ectatic vertebral artery: a novel neurovascular construct relieved by microsurgical decompression: Neurosurgery, 2005; 56; 117-24, pmid: 15799799 discussion 117–24

34. Grasso G, Alafaci C, Passalacqua M, Landmarks for vertebral artery repositioning in bulbar compression syndrome: anatomic and microsurgical nuances: Neurosurgery, 2005; 56; 160-64, pmid: 15799805 discussion 160–64

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750